| Ragnar Metals Limited (RAG) ORDINARY FULLY PAID |
Materials |
$17 |
Quarterly Activities Report
|
30 Jan 2026 1:18PM |
$0.034 |
$0.035 |
risen by
2.94%
|
|
RAG - Price-sensitive ASX Announcement
Full Release
Key Points
- Binding agreement to acquire up to 75% interest in Harnäs Gold Project.
- High-grade gold confirmed at Harnäs with samples up to 15.9 g/t Au.
- Strategic investments in Kaiser Reef and High-Tech Metals for gold production leverage.
- Plan to commence maiden diamond drilling at Harnäs in Q1 2026.
- Significant follow-up work programs including UAV magnetic survey.
- Ragnar aims to capitalize on high global gold prices.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ragnar Metals Limited (RAG) ORDINARY FULLY PAID |
Materials |
$17 |
Quarterly Cashflow Report
|
30 Jan 2026 1:18PM |
$0.034 |
$0.035 |
risen by
2.94%
|
|
RAG - Price-sensitive ASX Announcement
Full Release
Key Points
- Ragnar Metals Limited (ASX: RAG) reported a net decrease in cash of $302,000 for the quarter ending 31 December 2025.
- The company had cash and cash equivalents of $179,000 at the end of the quarter.
- Operating activities resulted in a cash outflow of $142,000, largely due to exploration and evaluation expenses.
- Investing activities saw a cash outflow of $161,000 for exploration and evaluation.
- There were no cash flows from financing activities during the quarter.
- The company expects to continue having negative operating cash flows as it is still in the exploration phase and not generating revenue.
- Ragnar Metals Limited plans to secure funds through successful exploration results and has access to a portfolio of liquid shares.
- Estimated quarters of funding available is 0.59, indicating less than 2 quarters of operational cash.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Munro Global Growth Fund (MAET) |
Financials |
$345 |
Monthly Portfolio Holdings - December 2025
|
30 Jan 2026 1:17PM |
$6.190 |
$6.190 |
fallen by
0%
|
|
| Ausbil GBL Essential Infra Fund (HDG) - Active ETF (GHIF) AUSBIL GBL ESSENTIAL INFRA FUND (HDG) - ACTIVE ETF |
- |
$287 |
Distribution reinvestment price for distribution 15 January
|
30 Jan 2026 1:17PM |
$12.640 |
$13.590 |
risen by
7.52%
|
|
| Ausbil Global Smallcap Fund - Active ETF (GSCF) |
Financials |
$128 |
Distribution reinvestment price for distribution 15 January
|
30 Jan 2026 1:16PM |
$18.190 |
$18.100 |
fallen by
0.49%
|
|
| Ausbil Active Dividend Income Fund - Active ETF (DIVI) |
Financials |
$575 |
Distribution reinvestment price for distribution 15 January
|
30 Jan 2026 1:16PM |
$11.380 |
$11.640 |
risen by
2.28%
|
|
| Bubs Australia Limited (BUB) ORDINARY FULLY PAID |
Consumer Staple |
$110 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
30 Jan 2026 1:13PM |
$0.130 |
$0.123 |
fallen by
5.77%
|
|
BUB - Price-sensitive ASX Announcement
Full Release
Key Points
- Bubs Australia Limited reported a 14% increase in half-year net revenue to $55.5 million compared to the previous year.
- Q2 FY26 net revenue rose by 17% to $29.9 million from Q1 FY26.
- The USA market is highlighted as the key growth engine, with a 47% increase in half-year net revenue.
- Net cash used in operating activities for Q2 was $3.5 million, contributing to a year-to-date total of $7.957 million.
- Bubs held $9.9 million cash at the end of December 2025, with an additional $10 million in undrawn debt facilities.
- Payments amounting to $380k were made to Key Management Personnel and $65k for Directors’ remuneration.
- Bubs is on track to receive FDA approval, with ongoing facilitation for the importation and distribution of its infant formula products in the US.
- The company maintained a gross margin of 49.3%, slightly down from 50% in the previous corresponding period.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Raptor Metals Ltd (RAP) ORDINARY FULLY PAID |
Materials |
$20 |
Application for quotation of securities - RAP
|
30 Jan 2026 1:10PM |
$0.064 |
$0.053 |
fallen by
17.19%
|
|
| Munro Concentrated Global Growth Fund (Managed Fund) (MCGG) |
Financials |
$86 |
Monthly Portfolio Holdings - December 2025
|
30 Jan 2026 1:09PM |
$14.630 |
$14.730 |
risen by
0.68%
|
|
| Munro Climate Change Leaders Fund (Managed Fund) (MCCL) |
Financials |
$176 |
Monthly Portfolio Holdings - December 2025
|
30 Jan 2026 1:09PM |
$17.890 |
$18.920 |
risen by
5.76%
|
|
| Magellan Global Fund (Open Class) (Managed Fund) (MGOC) |
Financials |
$5,577 |
MGOC - Quarterly portfolio disclosure - 31 December 2025
|
30 Jan 2026 1:08PM |
$2.820 |
$2.740 |
fallen by
2.84%
|
|
| Echo IQ Limited (EIQ) ORDINARY FULLY PAID |
Information Technology |
$390 |
Cleansing Notice
|
30 Jan 2026 1:08PM |
$0.500 |
$0.595 |
risen by
19%
|
|
| Magellan Infrastructure Fund (Currency Hedged) (MICH) |
Financials |
$553 |
MICH - Quarterly portfolio disclosure - 31 December 2025
|
30 Jan 2026 1:08PM |
$3.210 |
$3.460 |
risen by
7.79%
|
|
| Magellan Global Opportunities Fund - Active ETF (OPP) ORDINARY FULLY PAID |
Financials |
- |
OPPT - Quarterly portfolio disclosure - 31 December 2025
|
30 Jan 2026 1:07PM |
n/a |
n/a |
n/a
|
|
| Gullewa Limited (GUL) ORDINARY FULLY PAID |
Materials |
$24 |
Central Iron Ore Rights Issue
|
30 Jan 2026 1:07PM |
$0.105 |
$0.110 |
risen by
4.76%
|
|
GUL - Price-sensitive ASX Announcement
Full Release
Key Points
- Gullewa Limited's shareholding in Central Iron Ore increased to 70.5%.
- Participated in the rights issue by subscribing AUD$1,788,009.
- Acquired 23,143,594 shares at CAD$0.072 per share.
- Now holds 46,287,188 shares in Central Iron Ore.
- Company has 6,515,000 original warrants expiring on 30 April 2029.
- Also holds 23,143,594 new warrants expiring on 15 October 2030.
- ASX code for Gullewa Limited is GUL.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| EcoGraf Limited (EGR) ORDINARY FULLY PAID |
Materials |
$171 |
December 2025 Quarterly Activities Report and Appendix 5B
|
30 Jan 2026 1:06PM |
$0.390 |
$0.370 |
fallen by
5.13%
|
|
EGR - Price-sensitive ASX Announcement
Full Release
Key Points
- EcoGraf Limited's quarterly report for the period ending December 31, 2025, highlights their advancements in battery anode material production and exploration in Tanzania.
- The company received a $1.7 million Research and Development tax incentive from the Australian Taxation Office.
- EcoGraf entered a US$9 million farm-in agreement with AngloGold Ashanti for the Golden Eagle project in Tanzania.
- Epanko Graphite Project’s expansion aligns with plans to establish HFfree Purification Facilities in Europe, North America, and Asia.
- EcoGraf has $8.1 million in cash and cash equivalents as of December 31, 2025.
- The company continues to progress product qualification and anode recycling programs with battery manufacturers and electric vehicle OEMs.
- No production and development mining activities were undertaken during the quarter.
- The company held its Annual General Meeting on November 25, 2025, to update shareholders on business progress.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Paterson Resources Ltd (PSL) ORDINARY FULLY PAID |
Materials |
$24 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
30 Jan 2026 1:05PM |
$0.039 |
$0.043 |
risen by
10.26%
|
|
PSL - Price-sensitive ASX Announcement
Full Release
Key Points
- Completed Phase I of an 8,500m drilling campaign at the Grace Gold-Copper Project.
- Proceeds from a rights issue amounted to $752k with 41.8 million new shares issued.
- The Grace Gold-Copper Project is located in Western Australia’s Paterson Province.
- Initial assay results expected in early February.
- Net cash used in operating activities was $250k for the quarter.
- Cash and cash equivalents at end of the period was $2.583 million.
- Successfully completed a pro-rata non-renounceable entitlement issue.
- Estimated 3.85 quarters of funding available with current cash flow.
- Director Matthew Bull received shareholder approval for participation in a placement.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Airlie Australian Share Fund (Managed Fund) (AASF) |
Financials |
$996 |
AASF - Quarterly portfolio disclosure - 31 December 2025
|
30 Jan 2026 1:03PM |
$3.850 |
$3.840 |
fallen by
0.26%
|
|
| Echo IQ Limited (EIQ) ORDINARY FULLY PAID |
Information Technology |
$390 |
Application for quotation of securities - EIQ
|
30 Jan 2026 1:03PM |
$0.500 |
$0.595 |
risen by
19%
|
|
| RBR Group Limited (RBR) ORDINARY FULLY PAID |
Materials |
$4 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
30 Jan 2026 1:02PM |
$0.020 |
$0.029 |
risen by
45%
|
|
RBR - Price-sensitive ASX Announcement
Full Release
Key Points
- RBR Group reported net cash used in operating activities of AUD 68,000.
- Cash and cash equivalents at the end of the period were AUD 332,000.
- RBR is involved in the Mozambique LNG sector with tenders over USD 80 million.
- Completed a maintenance contract at Sasol-Temane project, earning AUD 230,000.
- Expansion of training and accommodation facilities at Shankara Village.
- Engaged in tender opportunities, including payroll management for Exxon Mobil.
- Focus on training services through Futuro Skills and partnerships.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Recce Pharmaceuticals Ltd (RCE) ORDINARY FULLY PAID |
Health Care |
$165 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
30 Jan 2026 1:01PM |
$0.600 |
$0.570 |
fallen by
5%
|
|
RCE - Price-sensitive ASX Announcement
Full Release
Key Points
- Advancement of Phase 3 clinical trial for Diabetic Foot Infections in Indonesia.
- Positive preclinical data for inhaled RECCE® 327 in pneumonia models.
- Granted a Hong Kong patent for anti-infectives.
- Received AUD $5.3 million R&D tax rebate; further rebates expected.
- Ended the quarter with a cash balance of AUD $0.4 million.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Clime Investment Management Ltd (CIW) ORDINARY FULLY PAID |
Financials |
$31 |
December 2025 Quarterly Update
|
30 Jan 2026 1:01PM |
$0.365 |
$0.370 |
risen by
1.37%
|
|
CIW - Price-sensitive ASX Announcement
Full Release
Key Points
- Closure of Clime Australian Income Fund and Clime Smaller Companies Fund significantly affected FUM.
- Total funds under management and advice decreased by 7.2% over the December quarter.
- Clime's next strategic phase focuses on transformation, simplification, and strategic initiatives for long-term value creation.
- Clime Capital Limited outperformed its benchmark, demonstrating strong portfolio management.
- John Abernethy returns to an operational role as Director of Investments.
- A significant divestment included a retail client book with approximately $99 million of FUA.
- Clime Private Wealth's integration with CPW/MTIS is progressing, impacting the balance sheet.
- Clime aims to announce an interim profit, despite previous losses, driven by business adjustments and improved focus.
- The company experienced adverse impacts from a withdrawn newspaper article, affecting the Clime Australian Income Fund.
- Clime enters the new phase with improved investment momentum and a strengthened leadership structure.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Monash IVF Group Limited (MVF) ORDINARY FULLY PAID |
Health Care |
$284 |
Rebecca Dean appointed Company Secretary & General Counsel
|
30 Jan 2026 1:00PM |
$0.705 |
$0.730 |
risen by
3.55%
|
|
| Eastern Resources Limited (EFE) ORDINARY FULLY PAID |
Materials |
$5 |
December 2025 Quarterly Cashflow Report
|
30 Jan 2026 1:00PM |
$0.044 |
$0.037 |
fallen by
15.91%
|
|
EFE - Price-sensitive ASX Announcement
Full Release
Key Points
- Eastern Resources Limited reported a decrease in cash and cash equivalents for the December 2025 quarter.
- Operating activities resulted in a net cash outflow of $20,000.
- Investing activities, primarily exploration and evaluation, led to a cash outflow of $160,000.
- The company did not engage in any significant financing activities during the quarter.
- The total cash and cash equivalents at the end of the period were $3,264,000.
- Payments to related parties amounted to $116,000, primarily for directors' fees and consulting services.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| identitii Limited (ID8) ORDINARY FULLY PAID |
Information Technology |
$5 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
30 Jan 2026 12:59PM |
$0.006 |
$0.006 |
fallen by
0%
|
|
ID8 - Price-sensitive ASX Announcement
Full Release
Key Points
- Five new customer contracts signed totaling $250k.
- BNDRY platform usage increased four-fold.
- Receipts from customers were $122k for Q2 FY26.
- Ended the quarter with a cash balance of $155k.
- Launched a $2.9m Rights Issue partially underwritten.
- Expecting R&D rebate from the ATO to improve cash flow.
- Partnership with Cherryhub aiding customer acquisition.
- Rights Issue subject to Takeovers Panel approval.
- Focus on disciplined execution and platform development.
- Anticipates ongoing support from shareholders.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
